natgillin/translations-raw huggingface dataset:
Licences for exports of beef and veal, pigment, eggs and poultrymeat attracting refunds
Izvozna dovoljenja z nadomestili za goveje in telečje meso, prašičje meso, jajca in perutninsko meso
By way of derogation from the second subparagraph of Article 10(1) of Regulation (EC) No 1445/95, Article 3(3) of Regulation (EC) No 1518/2003, Article 3(3) of Regulation (EC) No 596/2004 and Article 3(3) of Regulation (EC) No 633/2004, export licences applied for during the periods referred to in Annex III hereto shall be issued on the corresponding dates set out therein.
Z odstopanjem od drugega pododstavka člena 10(1) Uredbe (ES) št. 1445/95, člena 3(3) Uredbe (ES) št. 1518/2003, člena 3(3) Uredbe (ES) št. 596/2004 in člena 3(3) Uredbe (ES) št. 633/2004 se izvozna dovoljenja, za katera so bili zahtevki vloženi v obdobjih iz Priloge III te uredbe, izdajo na ustrezne datume iz navedene priloge.
The derogation provided for in the first paragraph shall apply only where no special measure as provided for in Article 10(2) of Regulation (EC) No 1445/95, Article 3(4) of Regulation (EC) No 1518/2003, Article 3(4) of Regulation (EC) No 596/2004 and Article 3(4) of Regulation (EC) No 633/2004 is taken before those dates of issue.
Odstopanje iz prvega pododstavka se uporablja le, če pred navedenimi datumi izdaje niso bili sprejeti nobeni posebni ukrepi iz člena 10(2) Uredbe (ES) št. 1445/95, člena 3(4) Uredbe (ES) št. 1518/2003, člena 3(4) Uredbe (ES) št. 596/2004 in člena 3(4) Uredbe (ES) št. 633/2004.
OJ L 161, 30.4.2004, p. 97, as corrected by OJ L 206, 9.6.2004, p. 37.
UL L 161, 30.4.2004, str. 97. Popravljena različica v UL L 206, 9.6.2004, str. 37.
Regulation as last amended by Regulation (EC) No 932/2007 (OJ L 204, 4.8.2007, p. 3).
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 932/2007 (UL L 204, 4.8.2007, str. 3).
Regulation as last amended by Regulation (EC) No 2019/2006.
Uredba, kakor je bila nazadnje spremenjena z Uredbo (ES) št. 2019/2006.
OJ L 122, 11.5.2007, p. 1.
UL L 122, 11.5.2007, str. 1.
Import licences for sweet potatoes to be issued under quotas 09.4013 and 09.4014 for certain periods of 2008
Izdaja uvoznih dovoljenj za sladki krompir v okviru kvot 09.4013 in 09.4014 za nekatera obdobja leta 2008
Dates of issue of licences
Datumi izdaje
Tuesday 18 March 2008
torek, 18. marec 2008
Friday 28 March 2008
petek, 28. marec 2008
Tuesday 29 April 2008
torek, 29. april 2008
Friday 9 May 2008
petek, 9. maj 2008
Import licences for manioc starch to be issued under quotas 09.4064 and 09.4065 for certain periods of 2008
Izdaja uvoznih dovoljenj za škrob iz manioke v okviru kvot 09.4064 in 09.4065 za nekatera obdobja leta 2008
Periods for lodging applications for licences for beef and veal, pigmeat, eggs and poultrymeat exports
Obdobja za vložitev zahtevkov za izvozna dovoljenja za goveje in telečje meso, prašičje meso, jajca in perutninsko meso
17 to 21 March 2008
Od 17. do 21. marca 2008
5 to 9 May 2008
Od 5. do 9. maja 2008
15 May 2008
maj 2008
14 to 18 July 2008
Od 14. do 18. julija 2008
24 July 2008
julij 2008
Commission Regulation (EC) No 1450/2007
Uredba Komisije (ES) št. 1450/2007
This Regulation shall enter into force on 11 December 2007.
Ta uredba začne veljati 11. decembra 2007.
to Commission Regulation of 10 December 2007 establishing the standard import values for determining the entry price of certain fruit and vegetables
k Uredbi Komisije z dne 10. decembra 2007 o določitvi pavšalnih uvoznih vrednosti za določanje vhodne cene nekaterega sadja in zelenjave
Commission Regulation (EC) No 1451/2007
Uredba Komisije (ES) št. 1451/2007
on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market
o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet
Having regard to Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market [1], and in particular Article 16(2) thereof,
ob upoštevanju Direktive 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet [1] in zlasti njenega člena 16(2),
Pursuant to Directive 98/8/EC, Member States may only authorise the placing on the market of biocidal products containing active substances included in Annex I, IA or IB to that Directive.
V skladu z Direktivo 98/8/ES lahko države članice dovolijo, da se dajo na trg le biocidni pripravki, ki vsebujejo aktivne snovi, navedene v prilogi I, IA ali IB k navedeni direktivi.
However, under the transitional measures provided for in Article 16(1) of Directive 98/8/EC Member States may allow the placing on the market of biocidal products containing active substances not listed in Annex I, IA or IB to Directive 98/8/EC which were already on the market on 14 May 2000, hereinafter ‘existing active substances’.
Vendar pa v skladu s prehodnimi ukrepi, zagotovljenimi v členu 16(1) Direktive 98/8/ES, države članice lahko dovolijo, da se dajo v promet biocidni pripravki, ki vsebujejo aktivne snovi, ki niso navedene v prilogi I, IA ali IB k Direktivi 98/8/ES in so že bile v prometu 14. maja 2000, v nadaljnjem besedilu „obstoječe aktivne snovi“.
Pursuant to paragraph 2 of that same Article, a 10-year programme of work is to be carried out for the review of all existing active substances.
V skladu z odstavkom 2 navedenega člena je treba izvesti desetletni delovni program za pregled vseh obstoječih aktivnih snovi.
This programme of work was intended to identify the existing active substances and determine those to be evaluated under the review programme with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC.
Namen tega delovnega programa je bil identificirati obstoječe aktivne snovi in določiti tiste, ki jih je treba oceniti v programu pregledovanja zaradi možne vključitve v prilogo I, IA ali IB k Direktivi 98/8/ES.
The initial phase of the programme was laid down in Commission Regulation (EC) No 1896/2000 of 7 September 2000 on the first phase of the programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council on biocidal products [2].
Začetna faza programa je bila določena v Uredbi Komisije (ES) št. 1896/2000 z dne 7. septembra 2000 o prvi fazi programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o biocidnih pripravkih [2].
Under Regulation (EC) No 1896/2000, existing active substances for use in biocidal products had to be identified, and those to be evaluated with a view to their possible inclusion in Annex I, IA or IB to Directive 98/8/EC in one or more product types had to be notified no later than 28 March 2002.
Po Uredbi (ES) št. 1896/2000 je bilo treba identificirati obstoječe aktivne snovi za uporabo v biocidnih pripravkih, tiste pa, ki jih je bilo treba oceniti zaradi možne vključitve v prilogo I, IA ali IB k Direktivi 98/8/ES v enem ali več vrstah pripravkov, je bilo treba prijaviti najpozneje do 28. marca 2002.
Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 [3] established a list of existing active substances.
Uredba Komisije (ES) št. 2032/2003 z dne 4. novembra 2003 o drugi fazi desetletnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta v zvezi z dajanjem biocidnih pripravkov v promet ter o spremembi Uredbe (ES) št. 1896/2000 [3] je uvedla seznam obstoječih aktivnih snovi.
That list covered active substances that had been identified in accordance with Article 3(1) or Article 5(2) of Regulation (EC) No 1896/2000 or in respect of which equivalent information had been submitted in a notification in accordance with Article 4(1) of that Regulation.
Ta seznam je zajemal aktivne snovi, ki so bile identificirane skladno s členom 3(1) ali členom 5(2) Uredbe (ES) št. 1896/2000 ali za katere so bili v prijavi predloženi enakovredni podatki v skladu s členom 4(1) te uredbe.
Regulation (EC) No 2032/2003 also established, in Annex II, an exhaustive list of existing active substances to be evaluated under the review programme.
Uredba (ES) št. 2032/2003 je v Prilogi II navedla tudi izčrpen seznam obstoječih aktivnih snovi, ki jih je treba oceniti v programu pregledovanja.
That list covered active substances in respect of which at least one notification had been accepted in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or in which a Member State had expressed an interest in accordance with Article 5(3) of that Regulation.
Ta seznam je zajemal aktivne snovi, za katere je bila sprejeta vsaj ena prijava v skladu s členom 4(2) Uredbe (ES) št. 1896/2000 ali za katero je država članica izrazila zanimanje v skladu s členom 5(3) te uredbe.
That list specified the product types concerned.
Na seznamu so navedene tudi zadevne vrste proizvodov.
Regulation (EC) No 2032/2003 allowed for a number of active substances or substance/product type combinations that were not originally covered by the review programme, to be examined on the same conditions as the active substances evaluated under the review programme, provided that interested operators submitted complete dossiers before 1 March 2006.
Uredba (ES) št. 2032/2003 je dovolila, da se nekaj aktivnih snovi ali kombinacij snovi/vrst proizvodov, ki jih prvotno ni urejal program pregledovanja, oceni pod istimi pogoji kot aktivne snovi, ocenjene v programu pregledovanja, če so zainteresirani gospodarski subjekti predložili popolne dosjeje pred 1. marcem 2006.
Article 4(2) of Regulation (EC) No 2032/2003 set 1 September 2006 as the date from which products containing active substances not examined under the review programme should be withdrawn from the market.
september 2006 je bil v členu 4(2) Uredbe (ES) št. 2032/2003 določen kot datum, na katerega je treba proizvode, ki vsebujejo aktivne snovi, ki niso bile ocenjene v programu pregledovanja, vzeti iz prometa.
Article 4(3) of Regulation (EC) No 2032/2003 provided that the existing active substances that had not been identified by the persons using them in biocidal products were to be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.
Člen 4(3) Uredbe (ES) št. 2032/2003 je določil, da se za obstoječe aktivne snovi, ki jih niso identificirale osebe, ki so jih uporabljale v biocidnih pripravkih, šteje, da niso bile dane v promet za biocidne namene pred 14. majem 2000.
However, this assimilation to new active substances should not be taken to mean that the unlawfully non-identified existing active substances may benefit from a provisional authorisation or from the longer data protection period reserved to genuinely new active substances.
Vendar pa ta izenačitev z novimi aktivnimi snovmi ne pomeni, da so nezakonito neidentificirane obstoječe aktivne snovi upravičene do začasnega dovoljenja ali do daljšega obdobja za varstvo podatkov, ki je namenjeno dejansko novim aktivnim snovem.
Whereas a clarification in that sense should be added to that provision.
K navedeni določbi je zato treba dodati pojasnilo v tem smislu.
Regulation (EC) No 2032/2003 introduced the possibility for Member States to apply for a derogation for biocidal products containing identified existing active substances that are not examined under the review programme, which Member States claim are essential for reasons of health, safety, or protection of cultural heritage or critical for the functioning of society in the absence of technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment or health.
Uredba (ES) št. 2032/2003 je uvedla možnost, da države članice zaprosijo za odstopanje za biocidne pripravke, ki vsebujejo identificirane obstoječe aktivne snovi, ki niso ocenjene v programu pregledovanja in za katere države članice trdijo, da so nujno potrebne zaradi zdravstvenih in varnostnih razlogov ali zaradi varovanja kulturne dediščine ali da so odločilnega pomena za delovanje družbe v odsotnosti tehnično in ekonomsko izvedljivih drugih možnosti ali nadomestkov, ki so sprejemljivi z okoljskega ali zdravstvenega vidika.
Such derogation is granted to the requesting Member States only if the requests are justified, if continued use does not give rise to concerns for human health and the environment, and if, where appropriate, alternatives are being developed.
Tako odstopanje se odobri državam članicam prosilkam samo, če so zahteve upravičene, če nadaljnja uporaba ne vzbuja pomislekov za zdravje ljudi in za okolje in če si, kjer je to primerno, prizadevajo najti tudi druge možnosti.
It is appropriate to continue to allow Member States to apply for such a derogation, including in respect of an active substance which it has been decided not to include in Annex I, IA or IB to Directive 98/8/EC.
Primerno je, da se še naprej dovoli državam članicam zaprositi za tovrstno odstopanje, vključno za aktivno snov, za katero je bilo odločeno, da se ne vključi v prilogo I, IA ali IB k Direktivi 98/8/ES.
Since the review programme referred to in Article 16(2) of Directive 98/8/EC runs only until 14 May 2010, any such derogation should not continue beyond that date.
Ker se program pregledovanja iz člena 16(2) Direktive 98/8/ES izvaja le do 14. maja 2010, se tovrstna odstopanja ne smejo nadaljevati po tem datumu.
Certain substances or products that are normally consumed by humans or animals for their subsistence may also be used to attract or to repel harmful organisms.
Nekatere snovi ali pripravki, ki jih običajno uživajo ljudje ali živali, se lahko uporabljajo tudi kot atraktanti ali repelenti škodljivih organizmov.
For these substances, there is general agreement that the authorisation/registration requirements of Directive 98/8/EC seem unjustified and that they should be expressly excluded from its scope.
Za te snovi splošno velja, da se zdijo zahteve glede dovoljenja in registracije iz Direktive 98/8/ES neupravičene in da bi jih bilo treba izrecno izključiti z njenega področja uporabe.
Considering that a revision of Directive 98/8/EC will take a significant amount of time during which the viability of those products on the market might be irreversibly affected, it is appropriate to postpone their withdrawal from the market until 14 May 2010.
Ker bo revizija Direktive 98/8/ES zahtevala veliko časa, v katerem bo morda sposobnost preživetja teh izdelkov na trgu nepopravljivo prizadeta, je primerno preložiti izločitev teh izdelkov iz prometa do 14. maja 2010.
A Member State which has indicated an interest in seeking review of a particular active substance should not be designated Rapporteur Member State for that substance.
Država članica, ki je izrazila zanimanje za uvedbo pregleda določene aktivne snovi, ne sme biti država članica poročevalka za navedeno snov.
In order to avoid duplication of work, and in particular to reduce testing involving vertebrate animals, the requirements concerning preparation and submission of the complete dossier should be such as to encourage those whose notifications have been accepted, hereinafter ‘participants’, to act collectively, in particular by submitting collective dossiers.
Da bi se izognili podvajanju dela in zlasti da bi zmanjšali poskuse na vretenčarjih, bi morale biti zahteve v zvezi s pripravo in predložitvijo popolnih dosjejev take, da spodbujajo tiste, katerih prijave so bile sprejete, v nadaljnjem besedilu „udeležence“, da delujejo skupaj, zlasti s predložitvijo skupnih dosjejev.
It should be possible for the Rapporteur Member State to make available the reference to any test involving vertebrate animals that has been carried out in respect of a notified existing active substance unless that reference is confidential under Article 19 of Directive 98/8/EC.
Država članica poročevalka bi morala imeti možnost, da zagotovi navedbo vsakršnega poskusa, ki vključuje vretenčarje in je bil opravljen v zvezi s prijavljenimi obstoječimi aktivnimi snovmi, razen kadar gre za zaupne navedbe po členu 19 Direktive 98/8/ES.
Also, in order to gain experience on the appropriateness of data requirements and to ensure that the review of active substances is carried out in a cost-effective way, participants should be encouraged to provide information on the costs of compiling a dossier and on the need to carry out tests on vertebrate animals.
Da bi lahko pridobili izkušnje glede primernosti zahtevanih podatkov in zagotovili izvedbo pregleda aktivnih snovi, ki bi bil stroškovno učinkovit, je treba udeležence tudi spodbuditi, da predložijo podatke o stroških sestave dosjejev in o potrebi po opravljanju poskusov na vretenčarjih.
In order to avoid delays, participants should start discussions as early as possible with Rapporteur Member States in order to resolve uncertainties in relation to data requirements.
Da bi se izognili zaostankom in da bi razrešili negotovosti v zvezi z zahtevanimi podatki, bi morali udeleženci čim prej začeti razpravo z državami članicami poročevalkami.
Applicants, other than participants, who wish to apply in accordance with Article 11 of Directive 98/8/EC for inclusion in Annex I, IA or IB thereto of an active substance/product type combination being evaluated under the review programme should submit complete dossiers for that combination no earlier or no later than participants so as not to disturb the smooth functioning of the review programme or create a disadvantage to the participants.
Prosilci, ki niso udeleženci in želijo v skladu s členom 11 Direktive 98/8/ES zaprositi za vključitev kombinacije aktivnih snovi/vrst pripravkov, ocenjene v programu pregledovanja, v prilogo I, IA ali IB k navedeni direktivi, ne smejo predložiti popolnih dosjejev pred ali za udeleženci, da s tem ne bi motili tekočega poteka programa pregledovanja ali oškodovali udeležencev.
The requirements concerning the content and format of dossiers and the number of dossiers to be submitted should be defined.
Opredeliti je treba zahteve v zvezi z vsebino in obliko dosjejev ter številom dosjejev, ki jih je treba predložiti.
Provision should be made for cases in which a participant is joined by a producer, formulator or association and in which a participant withdraws from the review programme.
Predvideti je treba primere, v katerih se udeležencu pridruži proizvajalec, formulator ali združenje in v katerih udeleženec odstopi iz programa pregledovanja.
Producers, formulators or associations should within certain time limits have the opportunity of taking over the role of participant for an existing active substance/product type combination in respect of which all participants have withdrawn or none of the dossiers meets the requirements.
Proizvajalci, formulatorji in združenja bi morali imeti možnost, da v določenih rokih prevzamejo vlogo udeleženca pri kombinaciji obstoječih aktivnih snovi/vrst pripravkov, v zvezi s katero so se vsi udeleženci umaknili ali noben od dosjejev ne izpolnjuje zahtev.
Subject to the same time-limits, it should also be possible in certain circumstances for Member States to indicate an interest and act as a participant for the inclusion in Annex I, IA or IB to Directive 98/8/EC of such a combination.
Ob upoštevanju istih rokov bi morale države članice v nekaterih okoliščinah imeti tudi možnost, da izrazijo zanimanje in da ravnajo kot udeleženci pri vključitvi take kombinacije v prilogo I, IA ali IB k Direktivi 98/8/ES.
In order to discourage abuse of the opportunity to maintain an active substance on the market while it is examined under the review programme, it should be possible for another person or a Member State to take over the role of participant only once in relation to a given active substance/product type combination.
Da se prepreči zloraba možnosti, da aktivna snov ostane v prometu, medtem ko jo ocenjujejo v programu pregledovanja, bi smela druga oseba ali država članica le enkrat prevzeti vlogo udeleženca v zvezi z dano kombinacijo aktivnih snovi/vrst pripravkov.
For the same purpose, a person or Member State taking over the role of participant should provide within a certain period evidence of commencing work on a complete dossier.
Iz istega razloga bi morala oseba ali država članica, ki prevzame vlogo udeleženca, v določenem roku predložiti dokaze o tem, da začenja sestavljati popoln dosje.
Time limits should be specified within which the Rapporteur Member States must verify the completeness of the dossiers.
Določiti je treba roke, v katerih bi morale države članice poročevalke preveriti popolnost dosjejev.
It should be possible, in exceptional circumstances, for the Rapporteur Member States to establish a new deadline for the submission of parts of a dossier, in particular where the participant has demonstrated that it was impossible to submit information in due time or in order to resolve uncertainties regarding data requirements that remain despite earlier discussions between the participant and the Rapporteur Member State.
V izjemnih okoliščinah bi morale imeti države članice poročevalke možnost, da določijo nov končni rok za predložitev delov dosjejev, zlasti če je udeleženec dokazal, da je bilo nemogoče predložiti podatke pravočasno, ali da bi razrešili negotovosti glede zahtevanih podatkov, ki še ostajajo kljub predhodnim razpravam med udeležencem in državo članico poročevalko.
For each existing active substance, the Rapporteur Member State should examine and evaluate the dossier and present the results to the Commission and the other Member States in the form of a competent authority report and a recommendation as to the decision to be taken with regard to the active substance concerned.
Država članica poročevalka bi morala proučiti in oceniti dosje za vsako obstoječo aktivno snov ter Komisiji in drugim državam članicam predložiti izsledke v obliki poročila pristojnega organa in priporočilo glede odločitve, ki jo je treba sprejeti v zvezi z zadevno aktivno snovjo.
In order not to prolong decision-making unnecessarily, the Rapporteur Member State should at the same time consider carefully the need for additional studies.
Da ne bi po nepotrebnem podaljšali odločanja, bi morala država članica poročevalka hkrati pazljivo preučiti potrebo po dodatnih študijah.
For the same reason, Rapporteur Member States should be obliged to take into consideration information submitted after acceptance of the dossier only under specified conditions.
Zaradi istega razloga bi morale države članice poročevalke le pod določenimi pogoji upoštevati podatke, ki so bili predloženi po sprejetju dosjeja.
The competent authority reports should be examined by the other Member States before the assessment reports are submitted to the Standing Committee on Biocidal Products.
Države članice bi morale preučiti poročila pristojnega organa, še preden so poročila o oceni izročena Stalnemu odboru za biocidne pripravke.
Where, despite a recommendation for inclusion of an active substance in Annex I, IA or IB to Directive 98/8/EC, concerns as referred to in Article 10(5) of that Directive remain, it should be possible for the Commission to take into account, but without prejudice to Article 12 of that Directive, the finalisation of the evaluation on other existing active substances applied for the same use.
Kadar kljub priporočilu za vključitev aktivne snovi v prilogo I, IA ali IB k Direktivi 98/8/ES še vedno ostajajo pomisleki iz člena 10(5) navedene direktive, bi morala imeti Komisija možnost, da ne glede na člen 12 navedene direktive upošteva dokončno oceno drugih obstoječih aktivnih snovi z enako uporabo.
Provision should be made for Rapporteur Member States to update competent authority reports where necessary.
Države članice poročevalke bi morale imeti možnost, da posodobijo poročila pristojnih organov, kadar je to potrebno.